Immunovant Inc
IMVT
Market Cap$2.9B
Close$
$4.71
72.2% downside
Current Fair Value
72.2% downsideOvervalued by 72.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.90 Billion |
|---|---|
| Enterprise Value | $2.20 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.73 |
| Beta | 0.61 |
| Outstanding Shares | 151,574,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.21 |
|---|---|
| PEG | -15.02 |
| Price to Sales | - |
| Price to Book Ratio | 4.24 |
| Enterprise Value to Revenue | 13755.8 |
| Enterprise Value to EBIT | -5.24 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
ESG Score
No data